Abstract

The simian immunodeficiency virus- (SIV-) infected rhesus macaque is the preferred animal model for vaccine development, but the correlates of protection in this model are not completely understood. In this paper, we document the cytotoxic T lymphocyte (CTL) response to SIV and its effects on viral evolution in an effort to identify events associated with disease progression regardless of MHC allele expression. We observed the evolution of epitopes targeted by CTLs in a group of macaques that included long-term nonprogressing (LTNP), slowly progressing (SP), normally progressing (NP), and rapidly progressing (RP) animals. Collectively, our data (1) identify novel CTL epitopes from an SP animal that are not restricted by known protective alleles, (2) illustrate that, in this small study, RP and NP animals accrue more mutations in CTL epitopes than in SP or LTNP macaques, and (3) demonstrate that the loss of CTL responses to immunodominant epitopes is associated with viral replication increases, which are not controlled by secondary CTL responses. These findings provide further evidence for the critical role of the primary cell-mediated immune responses in the control of retroviral infections.

Highlights

  • There is compelling evidence that the virus-specific cytotoxic T lymphocyte (CTL) response is an important factor in the control of human and simian immunodeficiency viruses (HIV and SIV, resp.) in infected individuals

  • Our data (1) identify novel CTL epitopes from an slowly progressing (SP) animal that are not restricted by known protective alleles, (2) illustrate that, in this small study, rapidly progressing (RP) and normally progressing (NP) animals accrue more mutations in CTL epitopes than in SP or long-term nonprogressing (LTNP) macaques, and (3) demonstrate that the loss of CTL responses to immunodominant epitopes is associated with viral replication increases, which are not controlled by secondary CTL responses

  • The CTL response is restricted by the repertoire of major histocompatibility complex (MHC) Class I molecules that present viral epitopes, and a greater knowledge of these allele: epitope combinations is vital for identifying antigenspecific CTLs and measuring effector functions of antiviral cellular immunity

Read more

Summary

Introduction

There is compelling evidence that the virus-specific cytotoxic T lymphocyte (CTL) response is an important factor in the control of human and simian immunodeficiency viruses (HIV and SIV, resp.) in infected individuals. The CTL response is restricted by the repertoire of major histocompatibility complex (MHC) Class I molecules that present viral epitopes, and a greater knowledge of these allele: epitope combinations is vital for identifying antigenspecific CTLs and measuring effector functions of antiviral cellular immunity. The expression of the rhesus macaque major histocompatibility complex (MHC) Class I molecule Mamu A∗01 has been determined to be associated with slower disease progression [3, 4], which is similar to the protective effects of HLA B∗57 expression in humans [5].

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call